2 results match your criteria: "and UCLA Clinical and Translational Science Institute[Affiliation]"
46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study.
Ann Intern Med
December 2017
From University of California, Los Angeles, Charles R. Drew University of Medicine and Science, and UCLA Clinical and Translational Science Institute, Los Angeles, California.
Background: No large population-based studies have been done on systemic lupus erythematosus (SLE) mortality trends in the United States.
Objective: To identify secular trends and population characteristics associated with SLE mortality.
Design: Population-based study using a national mortality database and census data.
The Healthy Community Neighborhood Initiative: Rationale and Design.
Ethn Dis
January 2016
Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at the University of California, Los Angeles (UCLA) and UCLA Clinical and Translational Science Institute.
Objective: To describe the design and rationale of the Healthy Community Neighborhood Initiative (HCNI), a multi-component study to understand and document health risk and resources in a low-income and minority community.
Design: A community-partnered participatory research project.
Setting: A low-income, biethnic African American and Latino neighborhood in South Los Angeles.